97
Views
8
CrossRef citations to date
0
Altmetric
Drug Evaluation

5T4-modified vaccinia ankara: progress in tumor-associated antigen-based immunotherapy

, DO
Pages 1463-1469 | Published online: 29 Aug 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Bruce Acres & Jean-Yves Bonnefoy. (2008) Clinical development of MVA-based therapeutic cancer vaccines. Expert Review of Vaccines 7:7, pages 889-893.
Read now
Liu Hong & Daiming Fan. (2008) Cancer mucosa antigens: novel immunotherapeutic targets. Expert Opinion on Therapeutic Targets 12:6, pages 749-756.
Read now

Articles from other publishers (5)

Alistair M Cook, Andrea Khong, Anna K Nowak & Richard A Lake. (2015) Novel insights into the pathophysiology and treatment of malignant pleural mesothelioma. Lung Cancer Management 4:5, pages 249-259.
Crossref
Robert J AmatoMika Stepankiw. (2012) Evaluation of MVA-5T4 as a novel immunotherapeutic vaccine in colorectal, renal and prostate cancer. Future Oncology 8:3, pages 231-237.
Crossref
Robert J. AmatoMika Stepankiw. (2012) Clinical Efficacy of TroVax in the Treatment of Progressive Castration-resistant Prostate Cancer. Clinical Medicine Insights: Oncology 6, pages CMO.S7654.
Crossref
Ran TaoLian LiWenlin HuangLimin Zheng. (2010) Activation of Human Dendritic Cells by Recombinant Modified Vaccinia Virus Ankara Vectors Encoding Survivin and IL-2 Genes In Vitro . Human Gene Therapy 21:1, pages 98-108.
Crossref
Swethajit Biswas & Tim Eisen. (2009) Immunotherapeutic strategies in kidney cancer—when TKIs are not enough. Nature Reviews Clinical Oncology 6:8, pages 478-487.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.